Proposed issue of securities
Proposed issue of securities
Proposed issue of securities
Change in substantial holding
Appendix 4C – quarterly
Appendix 4G
Invitrocue launches world’s first commercial Personalised Cancer Screening Service: Onco-PDO™
Half Yearly Report and Accounts
Invitrocue secures grant from Northern Ireland to commercialise Onco-PDO
Investor presentation
Change of Director’s Interest Notice – Jamie Khoo
Change of Director’s Interest Notice – Steven Fang